drugset / Trial / NCT03191136

Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers

NCT03191136

Phase 1 Completed 24 enrolled Yuhan Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This is a phase 1, open-label, randomized, single dose, crossover clinical trial to assess the effect of food on the pharmacokinetics of YHD1119 in healthy male volunteers. Hypothesis: "YHD1119" is showing equal equal pharmacokinetics in fasted and fed state.

Timeline

Start
2017-05-10
Primary completion
2017-06-27
Completion
2017-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 300 mg Oral

Indications